Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other neoplasm 1Dermatologic 1

Conditions

Melanoma 19Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Prostatic Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Lung Neoplasms 2Kidney Neoplasms 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Uveal Melanoma 1Urinary Bladder Neoplasms 1Testicular Neoplasms 1Sarcoma 1Precancerous Conditions 1Pancreatic Neoplasms 1Lymphoma, T-Cell, Cutaneous 1Hepatitis C 1Disease Progression 1Carcinoma, Merkel Cell 1Biliary Tract Neoplasms 1

Interventions

Cyclophosphamide 6fludarabine phosphate 5Peripheral Blood Stem Cell Transplantation 5Cyclosporine 4Antilymphocyte Serum 4Aminolevulinic Acid 4Whole-Body Irradiation 3Tacrolimus 3Mycophenolic Acid 3Methotrexate 3Etoposide 3Epoetin Alfa 3Darbepoetin alfa 3Busulfan 3Sirolimus 2Morphine 2Methylprednisolone 2Melphalan 2Filgrastim 2Biopsy 2tremelimumab 1tirbanibulin 1pyroxamide 1perillyl alcohol 1ferrous sulfate 1ferric gluconate 1arginine butyrate 1Triamcinolone 1Therapeutics 1Tetradecanoylphorbol Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precancerous Conditions × tremelimumab × Dermatologic × Clear all
NCT00897312 2016-04-25

Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease

Vanderbilt-Ingram Cancer Center

Terminated
7 enrolled
DermatologicOther neoplasm

Hepatitis C, Melanoma, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡